Growth Metrics

Karyopharm Therapeutics (KPTI) Amortizatization of Intangibles (2016 - 2025)

Historic Amortizatization of Intangibles for Karyopharm Therapeutics (KPTI) over the last 11 years, with Q4 2025 value amounting to $9000.0.

  • Karyopharm Therapeutics' Amortizatization of Intangibles fell 9770.41% to $9000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $410000.0, marking a year-over-year decrease of 8362.62%. This contributed to the annual value of $410000.0 for FY2025, which is 8362.62% down from last year.
  • Latest data reveals that Karyopharm Therapeutics reported Amortizatization of Intangibles of $9000.0 as of Q4 2025, which was down 9770.41% from $45000.0 recorded in Q3 2025.
  • In the past 5 years, Karyopharm Therapeutics' Amortizatization of Intangibles registered a high of $1.1 million during Q1 2023, and its lowest value of -$664000.0 during Q1 2021.
  • Its 5-year average for Amortizatization of Intangibles is $313850.0, with a median of $263000.0 in 2022.
  • Per our database at Business Quant, Karyopharm Therapeutics' Amortizatization of Intangibles crashed by 543333.33% in 2021 and then skyrocketed by 260222.22% in 2023.
  • Over the past 5 years, Karyopharm Therapeutics' Amortizatization of Intangibles (Quarter) stood at -$138000.0 in 2021, then skyrocketed by 436.23% to $464000.0 in 2022, then soared by 120.04% to $1.0 million in 2023, then crashed by 61.61% to $392000.0 in 2024, then plummeted by 97.7% to $9000.0 in 2025.
  • Its Amortizatization of Intangibles stands at $9000.0 for Q4 2025, versus $45000.0 for Q3 2025 and $120000.0 for Q2 2025.